ARTICLE | Company News
Cancer Research UK, Monopar Therapeutics deal
August 10, 2015 7:00 AM UTC
Cancer Research UK will fund and complete preclinical development of Monopar’s HuATN-658 and conduct a Phase I trial of the product in cancer patients. Upon completion of the Phase I trial, Monopar wi...